Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal motor activity	KIF21B MYH1 MYH4 MYH13 MYO9B MYO15A KIF13A DNAH9	1.22e-05	118	181	8	GO:0003774
GeneOntologyMolecularFunction	microfilament motor activity	MYH1 MYH4 MYH13 MYO9B MYO15A	2.28e-05	38	181	5	GO:0000146
GeneOntologyMolecularFunction	L-glutamine, sodium:proton antiporter activity	SLC38A5 SLC38A3	8.17e-05	2	181	2	GO:0140830
GeneOntologyMolecularFunction	actin filament binding	MYH1 FLNB MYH4 MYH13 MYO9B GAS7 SHROOM4 AFDN MYO15A	2.34e-04	227	181	9	GO:0051015
GeneOntologyMolecularFunction	calcium ion binding	GPD2 PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 CLSTN2 CPS1 TENM2 SVEP1 PCDHB16 USP6 PLA2G4C MEGF8 VCAN ITSN2 SCUBE3	4.83e-04	749	181	17	GO:0005509
GeneOntologyMolecularFunction	L-asparagine transmembrane transporter activity	SLC38A5 SLC38A3	4.84e-04	4	181	2	GO:0015182
GeneOntologyMolecularFunction	ATP-dependent activity	KIF21B DHX36 MYH1 MYH4 ERCC2 ERCC6 MYH13 MYO9B ZNFX1 CPOX FIGN ATP6V0D1 MYO15A KIF13A DNAH9	4.92e-04	614	181	15	GO:0140657
GeneOntologyMolecularFunction	small GTPase binding	MYO9B EXPH5 TMEM127 ADCYAP1R1 SH3BP4 ARHGAP1 NPC1L1 AFDN DEPDC5 PLCE1	7.19e-04	321	181	10	GO:0031267
GeneOntologyMolecularFunction	basic amino acid transmembrane transporter activity	SLC38A5 SLC7A7 SLC38A3	7.45e-04	20	181	3	GO:0015174
GeneOntologyMolecularFunction	L-histidine transmembrane transporter activity	SLC38A5 SLC38A3	8.03e-04	5	181	2	GO:0005290
GeneOntologyMolecularFunction	amino acid:monoatomic cation antiporter activity	SLC38A5 SLC38A3	8.03e-04	5	181	2	GO:0140848
GeneOntologyCellularComponent	myosin complex	MYH1 MYH4 MYH13 MYO9B MYO15A	1.62e-04	59	182	5	GO:0016459
GeneOntologyCellularComponent	ISGF3 complex	STAT1 STAT2	2.25e-04	3	182	2	GO:0070721
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH4 MYH13	3.34e-04	16	182	3	GO:0005859
Domain	IQ	MYH1 MYH4 MYH13 MYO9B SCN5A CAMTA1 MYO15A	1.41e-05	81	182	7	SM00015
Domain	Cadherin	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 CLSTN2 FREM1 PCDHB16	2.05e-05	118	182	8	IPR002126
Domain	IQ_motif_EF-hand-BS	MYH1 MYH4 MYH13 MYO9B SCN5A CAMTA1 MYO15A	2.81e-05	90	182	7	IPR000048
Domain	Myosin_head_motor_dom	MYH1 MYH4 MYH13 MYO9B MYO15A	3.22e-05	38	182	5	IPR001609
Domain	MYOSIN_MOTOR	MYH1 MYH4 MYH13 MYO9B MYO15A	3.22e-05	38	182	5	PS51456
Domain	Myosin_head	MYH1 MYH4 MYH13 MYO9B MYO15A	3.22e-05	38	182	5	PF00063
Domain	MYSc	MYH1 MYH4 MYH13 MYO9B MYO15A	3.22e-05	38	182	5	SM00242
Domain	IQ	MYH1 MYH4 MYH13 MYO9B SCN5A CAMTA1 MYO15A	3.48e-05	93	182	7	PS50096
Domain	Cadherin_2	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16	4.04e-05	65	182	6	PF08266
Domain	Cadherin_N	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16	4.04e-05	65	182	6	IPR013164
Domain	IQ	MYH1 MYH4 MYH13 MYO9B CAMTA1 MYO15A	6.68e-05	71	182	6	PF00612
Domain	CADHERIN_1	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 CLSTN2 PCDHB16	1.20e-04	113	182	7	PS00232
Domain	Cadherin	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 CLSTN2 PCDHB16	1.20e-04	113	182	7	PF00028
Domain	CADHERIN_2	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 CLSTN2 PCDHB16	1.27e-04	114	182	7	PS50268
Domain	-	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 CLSTN2 PCDHB16	1.27e-04	114	182	7	2.60.40.60
Domain	CA	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 CLSTN2 PCDHB16	1.34e-04	115	182	7	SM00112
Domain	Cadherin-like	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 CLSTN2 PCDHB16	1.42e-04	116	182	7	IPR015919
Domain	Rho_GTPase_activation_prot	STARD8 MYO9B ARHGAP1 SRGAP3 ARHGAP45 PLXNB1	2.20e-04	88	182	6	IPR008936
Domain	GPCR_2_secretin-like_CS	ADCYAP1R1 GHRHR ADGRA1 ADGRD1	3.22e-04	34	182	4	IPR017983
Domain	RhoGAP	STARD8 MYO9B ARHGAP1 SRGAP3 ARHGAP45	3.43e-04	62	182	5	SM00324
Domain	RhoGAP	STARD8 MYO9B ARHGAP1 SRGAP3 ARHGAP45	3.70e-04	63	182	5	PF00620
Domain	Myosin_N	MYH1 MYH4 MYH13	3.80e-04	15	182	3	PF02736
Domain	Myosin_N	MYH1 MYH4 MYH13	3.80e-04	15	182	3	IPR004009
Domain	RhoGAP_dom	STARD8 MYO9B ARHGAP1 SRGAP3 ARHGAP45	3.98e-04	64	182	5	IPR000198
Domain	RHOGAP	STARD8 MYO9B ARHGAP1 SRGAP3 ARHGAP45	3.98e-04	64	182	5	PS50238
Domain	-	STARD8 MYO9B ARHGAP1 SRGAP3 ARHGAP45	3.98e-04	64	182	5	1.10.555.10
Domain	Cadherin_tail	PCDHA8 PCDHA5 PCDHA3 PCDHA1	4.48e-04	37	182	4	PF15974
Domain	Cadherin_CBD	PCDHA8 PCDHA5 PCDHA3 PCDHA1	4.48e-04	37	182	4	IPR031904
Domain	Myosin_tail_1	MYH1 MYH4 MYH13	6.67e-04	18	182	3	PF01576
Domain	Myosin_tail	MYH1 MYH4 MYH13	6.67e-04	18	182	3	IPR002928
Domain	Cadherin_CS	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16	6.96e-04	109	182	6	IPR020894
Domain	Myosin-like_IQ_dom	MYH1 MYH4 MYH13	7.86e-04	19	182	3	IPR027401
Domain	-	MYH1 MYH4 MYH13	7.86e-04	19	182	3	4.10.270.10
Domain	CPSASE_1	ACACA CPS1	9.26e-04	5	182	2	PS00866
Domain	FCH	GAS7 SRGAP3 ARHGAP45	1.22e-03	22	182	3	SM00055
Domain	CPSASE_2	ACACA CPS1	1.38e-03	6	182	2	PS00867
Domain	FCH_dom	GAS7 SRGAP3 ARHGAP45	1.40e-03	23	182	3	IPR001060
Domain	7tm_2	ADCYAP1R1 GHRHR ADGRA1 ADGRD1	1.42e-03	50	182	4	PF00002
Domain	G_PROTEIN_RECEP_F2_2	ADCYAP1R1 GHRHR ADGRA1 ADGRD1	1.42e-03	50	182	4	PS00650
Domain	F_BAR	GAS7 SRGAP3 ARHGAP45	1.79e-03	25	182	3	IPR031160
Domain	F_BAR	GAS7 SRGAP3 ARHGAP45	1.79e-03	25	182	3	PS51741
Domain	STAT_TF_DNA-bd_sub	STAT1 STAT2	1.92e-03	7	182	2	IPR012345
Domain	STAT	STAT1 STAT2	1.92e-03	7	182	2	IPR001217
Domain	STAT_int	STAT1 STAT2	1.92e-03	7	182	2	SM00964
Domain	STAT_TF_DNA-bd	STAT1 STAT2	1.92e-03	7	182	2	IPR013801
Domain	STAT_bind	STAT1 STAT2	1.92e-03	7	182	2	PF02864
Domain	STAT_int	STAT1 STAT2	1.92e-03	7	182	2	PF02865
Domain	CbamoylP_synth_lsu-like_ATP-bd	ACACA CPS1	1.92e-03	7	182	2	IPR005479
Domain	-	STAT1 STAT2	1.92e-03	7	182	2	1.10.532.10
Domain	BC-like_N	ACACA CPS1	1.92e-03	7	182	2	IPR005481
Domain	STAT_alpha	STAT1 STAT2	1.92e-03	7	182	2	PF01017
Domain	-	STAT1 STAT2	1.92e-03	7	182	2	1.20.1050.20
Domain	STAT_TF_prot_interaction	STAT1 STAT2	1.92e-03	7	182	2	IPR013799
Domain	STAT_TF_coiled-coil	STAT1 STAT2	1.92e-03	7	182	2	IPR015988
Domain	-	STAT1 STAT2	1.92e-03	7	182	2	2.60.40.630
Domain	CPSase_L_D2	ACACA CPS1	1.92e-03	7	182	2	PF02786
Domain	Biotin_carb_N	ACACA CPS1	1.92e-03	7	182	2	PF00289
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16 CTCF	2.77e-08	58	187	7	30377227
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PRKD2 ERCC2 ATG10 ACACA MYO9B FOSL2 SLCO4A1 TMEM127 ST14 NSD3 SH3BP4 FOCAD NHSL1 OVOL1 SLC16A5 MEGF8 SCARB1 SCN5A KBTBD11 DEPDC5 MBD5 CRAMP1 RAD9A	3.36e-08	1105	187	23	35748872
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1	1.67e-07	24	187	5	24698270
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH4 MYH13	6.09e-07	4	187	3	10388558
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16	6.44e-07	57	187	6	32633719
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHA8 PCDHA5 PCDHA3 PCDHA1	1.05e-06	15	187	4	15640798
Pubmed	Human claspin is required for replication checkpoint control.	CHEK1 ITSN2 RAD9A	1.52e-06	5	187	3	12766152
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	FLNB OGT STARD8 CAND2 CNTRL NOL11 WDFY4 STAT1 NLGN3 PLAA INTS2 AOPEP SGPL1 VCAN PRKAA1 POP1 CAMTA1 KIF13A PLXNB1 NCKAP1L	1.81e-06	1084	187	20	11544199
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHA8 PCDHA5 PCDHA3 PCDHA1	1.82e-06	17	187	4	29911975
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16	1.85e-06	68	187	6	11230163
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHA8 PCDHA5 PCDHA3 PCDHA1	2.33e-06	18	187	4	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHA8 PCDHA5 PCDHA3 PCDHA1	2.33e-06	18	187	4	10662547
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16	2.59e-06	72	187	6	10380929
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH4 MYH13	3.02e-06	6	187	3	10077619
Pubmed	DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling.	STAT1 STAT2 IL6ST	3.02e-06	6	187	3	16014513
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16	3.05e-06	74	187	6	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16	3.85e-06	77	187	6	10835267
Pubmed	Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent.	MYH1 MYH4 STAT1 VCAN TNNI2	3.90e-06	44	187	5	26075897
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16	4.82e-06	80	187	6	10716726
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH4 MYH13	5.27e-06	7	187	3	35210422
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA8 PCDHA5 PCDHA3 PCDHA1	1.50e-05	28	187	4	15347688
Pubmed	Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes.	PCDHB15 SLC38A5 PCDHA8 PCDHA1 PCDHB16	1.69e-05	59	187	5	23754746
Pubmed	JAK-STAT and bone metabolism.	STAT1 STAT2 IL6ST	1.79e-05	10	187	3	24069548
Pubmed	Intersubspecific subcongenic mouse strain analysis reveals closely linked QTLs with opposite effects on body weight.	GPD2 NR4A2 FIGN	1.79e-05	10	187	3	21451961
Pubmed	Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation.	STAT1 STAT2	2.88e-05	2	187	2	12388709
Pubmed	BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells.	CHEK1 BCL6	2.88e-05	2	187	2	18346918
Pubmed	Involvement of cholesterol membrane transporter Niemann-Pick C1-like 1 in the intestinal absorption of lutein.	SCARB1 NPC1L1	2.88e-05	2	187	2	22579005
Pubmed	The CSB chromatin remodeler and CTCF architectural protein cooperate in response to oxidative stress.	ERCC6 CTCF	2.88e-05	2	187	2	26578602
Pubmed	Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha.	STAT1 STAT2	2.88e-05	2	187	2	8621447
Pubmed	Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2.	STAT1 STAT2	2.88e-05	2	187	2	16501077
Pubmed	Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction.	STAT1 STAT2	2.88e-05	2	187	2	11932384
Pubmed	Expression and function of glutamine transporters SN1 (SNAT3) and SN2 (SNAT5) in retinal Müller cells.	SLC38A5 SLC38A3	2.88e-05	2	187	2	16249471
Pubmed	Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles.	SCARB1 NPC1L1	2.88e-05	2	187	2	17442616
Pubmed	Identification of zinc finger protein Bcl6 as a novel regulator of early adipose commitment.	BCL6 STAT1	2.88e-05	2	187	2	27251748
Pubmed	A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis.	STAT1 STAT2	2.88e-05	2	187	2	17442890
Pubmed	TRIM3 regulates the motility of the kinesin motor protein KIF21B.	KIF21B TRIM3	2.88e-05	2	187	2	24086586
Pubmed	The Cellular Response to Oxidatively Induced DNA Damage and Polymorphism of Some DNA Repair Genes Associated with Clinicopathological Features of Bladder Cancer.	ERCC2 ERCC6	2.88e-05	2	187	2	26649138
Pubmed	Growth and muscle defects in mice lacking adult myosin heavy chain genes.	MYH1 MYH4	2.88e-05	2	187	2	9382868
Pubmed	Postnatal myosin heavy chain isoform expression in normal mice and mice null for IIb or IId myosin heavy chains.	MYH1 MYH4	2.88e-05	2	187	2	11150240
Pubmed	Cooperative Transcriptional Activation of Antimicrobial Genes by STAT and NF-κB Pathways by Concerted Recruitment of the Mediator Complex.	STAT1 STAT2	2.88e-05	2	187	2	26146080
Pubmed	Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS.	STAT1 STAT2	2.88e-05	2	187	2	15850655
Pubmed	Structural analysis of the STAT1:STAT2 heterodimer revealed the mechanism of Sendai virus C protein-mediated blockade of type 1 interferon signaling.	STAT1 STAT2	2.88e-05	2	187	2	28978648
Pubmed	Identification of amino-acid residues in the V protein of peste des petits ruminants essential for interference and suppression of STAT-mediated interferon signaling.	STAT1 STAT2	2.88e-05	2	187	2	25965795
Pubmed	CTCF/cohesin-mediated DNA looping is required for protocadherin α promoter choice.	PCDHA1 CTCF	2.88e-05	2	187	2	23204437
Pubmed	Hepatitis C virus expression suppresses interferon signaling by degrading STAT1.	STAT1 STAT2	2.88e-05	2	187	2	15825084
Pubmed	Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors.	CHEK1 CCNB1	2.88e-05	2	187	2	18671143
Pubmed	STAT2 hypomorphic mutant mice display impaired dendritic cell development and antiviral response.	STAT1 STAT2	2.88e-05	2	187	2	19272190
Pubmed	MBD5 regulates NMDA receptor expression and seizures by inhibiting Stat1 transcription.	STAT1 MBD5	2.88e-05	2	187	2	36997128
Pubmed	DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.	BCL6 CTCF	2.88e-05	2	187	2	20733034
Pubmed	STAT2-dependent restriction of Zika virus by human macrophages but not dendritic cells.	STAT1 STAT2	2.88e-05	2	187	2	33979266
Pubmed	Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus.	BCL6 CTCF	2.88e-05	2	187	2	24362533
Pubmed	The role of Siglec-1 and SR-BI interaction in the phagocytosis of oxidized low density lipoprotein by macrophages.	SCARB1 SIGLEC1	2.88e-05	2	187	2	23520536
Pubmed	Interaction of mumps virus V protein variants with STAT1-STAT2 heterodimer: experimental and theoretical studies.	STAT1 STAT2	2.88e-05	2	187	2	20937132
Pubmed	Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells.	STAT1 STAT2	2.88e-05	2	187	2	10446176
Pubmed	TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating TH1/TH17 Cell Response.	MYO9B SH2D2A	2.88e-05	2	187	2	33046503
Pubmed	NPC1L1 and SR-BI are involved in intestinal cholesterol absorption from small-size lipid donors.	SCARB1 NPC1L1	2.88e-05	2	187	2	18373109
Pubmed	Bcl6 promotes osteoblastogenesis through Stat1 inhibition.	BCL6 STAT1	2.88e-05	2	187	2	25597995
Pubmed	Respective contributions of intestinal Niemann-Pick C1-like 1 and scavenger receptor class B type I to cholesterol and tocopherol uptake: in vivo v. in vitro studies.	SCARB1 NPC1L1	2.88e-05	2	187	2	21929836
Pubmed	Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells.	STAT1 STAT2	2.88e-05	2	187	2	21795355
Pubmed	The genomic structure of the STAT genes: multiple exons in coincident sites in Stat1 and Stat2.	STAT1 STAT2	2.88e-05	2	187	2	7885841
Pubmed	Chk1 Activation Protects Rad9A from Degradation as Part of a Positive Feedback Loop during Checkpoint Signalling.	CHEK1 RAD9A	2.88e-05	2	187	2	26658951
Pubmed	PHLPP1 counter-regulates STAT1-mediated inflammatory signaling.	STAT1 PHLPP1	2.88e-05	2	187	2	31408005
Pubmed	Expression and function of system N glutamine transporters (SN1/SN2 or SNAT3/SNAT5) in retinal ganglion cells.	SLC38A5 SLC38A3	2.88e-05	2	187	2	18689705
Pubmed	Glucosamine regulates hepatic lipid accumulation by sensing glucose levels or feeding states of normal and excess.	OGT PRKAA1	2.88e-05	2	187	2	32663610
Pubmed	Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins.	STAT1 STAT2	2.88e-05	2	187	2	15650219
Pubmed	Respiratory syncytial virus inhibits interferon-alpha-inducible signaling in macrophage-like U937 cells.	STAT1 STAT2	2.88e-05	2	187	2	16978698
Pubmed	Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer.	CHEK1 CCNB1	2.88e-05	2	187	2	24971465
Pubmed	The Involvement of ERCC2/XPD and ERCC6/CSB Wild Type Alleles in Protection Against Aging and Cancer.	ERCC2 ERCC6	2.88e-05	2	187	2	28707579
Pubmed	High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.	BCL6 FUT3	2.88e-05	2	187	2	28671040
Pubmed	Regulation of renal amino acid transporters during metabolic acidosis.	SLC7A7 SLC38A3	2.88e-05	2	187	2	17003226
Pubmed	STAT family of transcription factors in cytokine-mediated biological responses.	STAT1 STAT2	2.88e-05	2	187	2	10817963
Pubmed	Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann-Pick C1-like 1.	SCARB1 NPC1L1	2.88e-05	2	187	2	18641187
Pubmed	[STAT1 and STAT2 participate in growth inhibition of human hepatoma HepG2 cells induced by phosphatidylethanolamine].	STAT1 STAT2	2.88e-05	2	187	2	21354905
Pubmed	Isolation and characterization of a novel acetyl-CoA carboxylase kinase from rat liver.	ACACA PRKAA1	2.88e-05	2	187	2	7907095
Pubmed	Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation.	STAT1 STAT2	2.88e-05	2	187	2	14557668
Pubmed	A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses.	STAT1 STAT2	2.88e-05	2	187	2	32759968
Pubmed	NR4A2 haploinsufficiency is associated with intellectual disability and autism spectrum disorder.	GPD2 NR4A2	2.88e-05	2	187	2	29770430
Pubmed	Inhibition of IFN-alpha/beta signaling by two discrete peptides within measles virus V protein that specifically bind STAT1 and STAT2.	STAT1 STAT2	2.88e-05	2	187	2	19007958
Pubmed	A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma.	STAT1 STAT2	2.88e-05	2	187	2	34943910
Pubmed	Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice.	MYH1 MYH4	2.88e-05	2	187	2	11744674
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIF21B DHX36 CAND2 JADE3 PCDHA3 STOX2 INTS2 MDC1 KBTBD11 DEPDC5 CRAMP1 PLXNB1	3.26e-05	529	187	12	14621295
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PRKD2 ERCC2 ZNF219 OGT ERCC6 GAS7 FASTKD5 CLSTN2 CHEK1 NSD3 DNASE2B CTCF SGPL1 SCN5A CIAO2B CIZ1 SIGLEC1 USP54	3.64e-05	1116	187	18	31753913
Pubmed	PTEN identified as important risk factor of chronic obstructive pulmonary disease.	ERCC2 ERCC6 GC CHEK1 ALDH1L1 BCL6 STAT1 RGS6 CD14 SCARB1	3.84e-05	374	187	10	19625176
Pubmed	Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.	ERCC2 ERCC6 GC CHEK1 ALDH1L1 BCL6 STAT1 RGS6 CD14 SCARB1	4.49e-05	381	187	10	18676680
Pubmed	Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.	ERCC2 ERCC6 GC CHEK1 ALDH1L1 BCL6 STAT1 RGS6 CD14 SCARB1	4.59e-05	382	187	10	19170196
Pubmed	Loss of Prox1 in striated muscle causes slow to fast skeletal muscle fiber conversion and dilated cardiomyopathy.	MYH1 MYH4 TNNI2	5.33e-05	14	187	3	24938781
Pubmed	The DNA sequence and comparative analysis of human chromosome 5.	PCDHA8 PCDHA5 PCDHA3 PCDHA1 TENM2	5.42e-05	75	187	5	15372022
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DHX36 OGT SLCO4A1 ZNFX1 LMBRD2 MAP3K6 SH3BP4 SGPL1 PRKAA1 POP1 AFDN PLXNB1 PLCE1	5.56e-05	650	187	13	38777146
Pubmed	A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: the EUROSPAN project.	PDE3A PTPRG ADGRD1	6.64e-05	15	187	3	20031603
Pubmed	Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype.	MYH1 MYH4 TNNI2	6.64e-05	15	187	3	24852826
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	HIVEP1 ACACA EXPH5 PARP8 CHEK1 MAP3K6 NSD3 SH3BP4 NHSL1 STOX2 MEGF8 AFDN USP54 MAP3K21 KIF13A	7.11e-05	861	187	15	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TENM2 PCDHB16 STRIP2 FOCAD MEGF8 SRGAP3 ITSN2 CAMTA1 PLCE1 PDZD2	7.76e-05	407	187	10	12693553
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	STARD8 LRRN1 EXPH5 GAS7 TRIM14 WDFY4 SHROOM4 NLGN3 SGPL1 POP1 MBD5	8.06e-05	493	187	11	15368895
Pubmed	MusTRD can regulate postnatal fiber-specific expression.	MYH1 MYH4 TNNI2	8.14e-05	16	187	3	16494860
Pubmed	A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.	MYH1 MYH4 TNNI2	8.14e-05	16	187	3	19922871
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH4	8.60e-05	3	187	2	26059207
Pubmed	AMPK activation by SC4 inhibits noradrenaline-induced lipolysis and insulin-stimulated lipogenesis in white adipose tissue.	ACACA PRKAA1	8.60e-05	3	187	2	34668531
Pubmed	Simultaneous loss of skeletal muscle myosin heavy chain IIx and IIb causes severe skeletal muscle hypoplasia in postnatal mice.	MYH1 MYH4	8.60e-05	3	187	2	36515178
Pubmed	AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation.	ACACA PRKAA1	8.60e-05	3	187	2	30018077
Pubmed	AMPK couples plasma renin to cellular metabolism by phosphorylation of ACC1.	ACACA PRKAA1	8.60e-05	3	187	2	23785098
Cytoband	5q31	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16	8.21e-06	115	187	6	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16 CD14	2.37e-04	298	187	7	chr5q31
GeneFamily	Clustered protocadherins	PCDHB15 PCDHA8 PCDHA5 PCDHA3 PCDHA1 PCDHB16	5.23e-06	64	125	6	20
GeneFamily	Myosin heavy chains	MYH1 MYH4 MYH13	1.38e-04	15	125	3	1098
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	STARD8 ARHGAP1 SRGAP3 ARHGAP45	3.92e-04	50	125	4	721
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	GAS7 SRGAP3 ARHGAP45	5.16e-04	23	125	3	1288
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	CD14 CD163L1 SCARB1	8.36e-04	27	125	3	1253
GeneFamily	WD repeat domain containing\|ERCC excision repair associated	ERCC2 ERCC6	9.73e-04	7	125	2	1268
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDFY4 NSMAF	1.65e-03	9	125	2	1230
Coexpression	GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP	SGMS2 FOSL2 PARP8 NR4A2 CPOX BCL6 SH3BP4 CD14 VCAN NCKAP1L	1.87e-06	200	187	10	M8698
Coexpression	BERNARD_PPAPDC1B_TARGETS_DN	SUSD4 NSD3 PTPRG ARHGAP45 IL6ST PLCE1	4.01e-06	59	187	6	M8123
Coexpression	GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	KIF21B PRKD2 RHBDL1 CPOX BCL6 ITSN2 DEPDC5 HDAC10	2.55e-05	165	187	8	M9105
Coexpression	AIZARANI_LIVER_C23_KUPFFER_CELLS_3	CNTRL GAS7 BCL6 SLC7A7 TMEM127 CREB5 CD14 VCAN SECTM1	3.17e-05	221	187	9	M39124
Coexpression	GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN	TENT5A PARP8 ZNFX1 NUDT13 STAT1 NSD3 PHLPP1 NSMAF	4.21e-05	177	187	8	M8666
Coexpression	FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP	FLNB SGMS2 TENT5A TENM2 VCAN AFDN	4.61e-05	90	187	6	M48360
Coexpression	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	TENT5A ETV7 ZNFX1 STAT1 STAT2 SIGLEC1 RAD9A SECTM1	8.33e-05	195	187	8	M4292
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN	TENT5A ETV7 ZNFX1 STAT2 PCDHB16 SIGLEC1 RAD9A SECTM1	8.63e-05	196	187	8	M4267
Coexpression	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	ACACA CHEK1 STAT1 CCNB1 MDC1 RAD9A	8.79e-05	101	187	6	M15356
Coexpression	HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE	SGMS2 JADE3 MYO9B TENT5A FOSL2 NR4A2 GAS7 RIOK3 BCL6 TMEM127 WDFY4 LENG9 ST14 CREB5 SH3BP4 ARHGAP1 ZNF100 SLC16A5 SCARB1 KIF13A WDR17 NCKAP1L	8.96e-05	1250	187	22	M41099
Coexpression	GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	PRKD2 TENT5A ETV7 TRIM14 STAT1 STAT2 PDZD2 SECTM1	9.26e-05	198	187	8	M8969
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN	TENT5A ZNFX1 TRIM14 STAT1 STAT2 SIGLEC1 RAD9A SECTM1	9.26e-05	198	187	8	M4264
Coexpression	GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	STARD8 FOSL2 NR4A2 SLCO4A1 SH2D2A CREB5 ATP6V0D1 IL6ST	9.59e-05	199	187	8	M9751
Coexpression	GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	PDE3A FOSL2 ETV7 BCL6 TRIM14 STAT1 STAT2 SECTM1	9.59e-05	199	187	8	M8971
Coexpression	GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP	NR4A2 CREG1 NSD3 ROPN1L ATP6V0D1 DEPDC5 TNNI2 NSMAF	9.93e-05	200	187	8	M5985
Coexpression	GSE42724_NAIVE_VS_B1_BCELL_UP	PARP8 TRIM14 NUDT13 STAT2 SH3BP4 VCAN CIAO2B SECTM1	9.93e-05	200	187	8	M9790
Coexpression	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	PRKD2 HIVEP1 TENT5A ETV7 TRIM14 STAT1 STAT2 SECTM1	9.93e-05	200	187	8	M8967
Coexpression	HELLER_HDAC_TARGETS_UP	ACACA VRK3 MYO9B NR4A2 BCL6 RTN2 STAT1 ATP6V0D1 CAMTA1 RAD9A	9.95e-05	317	187	10	M3335
Coexpression	GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL	ACTRT3 NR4A2 CREG1 WDFY4 CD14 CD163L1 SIGLEC1 NSMAF SECTM1 NCKAP1L	1.19e-04	324	187	10	M39160
Coexpression	CUI_TCF21_TARGETS_2_DN	GPD2 ATG10 HIVEP1 STARD8 TENT5A RIOK3 TENM2 STAT1 PTPRG PRKAA1 ITSN2 KBTBD11 PHLPP1 MBD5 IL6ST NSMAF PLCE1	1.42e-04	854	187	17	M1533
Coexpression	MATZUK_OVULATION	PDE3A SCARB1 IL6ST	1.53e-04	15	187	3	M1807
Coexpression	CAIRO_HEPATOBLASTOMA_CLASSES_DN	CYP2B6 GC BCL6 SVEP1 PLA2G4C SGPL1 DEPDC5 IL6ST	1.53e-04	213	187	8	M12176
Coexpression	GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	DHX36 TRIM14 STAT1 STAT2 NSD3 CTCF DEPDC5	1.57e-04	160	187	7	M8664
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TENT5A ETV7 BCL6 CREB5 SH3BP4 CD14 CD163L1 VCAN SECTM1	2.07e-08	157	185	9	a98d06cef80bfe8481b0940abce2b29675e45812
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TENT5A ETV7 BCL6 CREB5 SH3BP4 CD14 CD163L1 VCAN SECTM1	3.36e-08	166	185	9	28a44448a0b0d72459e8fe84ce5d666f16f514b3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TENT5A ETV7 BCL6 CREB5 SH3BP4 CD14 CD163L1 VCAN SECTM1	3.36e-08	166	185	9	2a04915d534a83e65aa168435d6856125b5bdd78
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DHX36 IGDCC3 PCDHA5 PCDHA3 CLSTN2 STOX2 SRGAP3 AFDN PLCE1	9.78e-08	188	185	9	e239bcdbd210a398a5850cb6fbf171d402f45a4f
ToppCell	COVID-19_Moderate-Classical_Monocyte\|COVID-19_Moderate / disease group, cell group and cell class	GAS7 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 KIF13A SECTM1	1.46e-07	197	185	9	98d4107e457e7399a84439acd73bf8f59598971b
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.52e-07	198	185	9	d347462ba6cb1c5a59c86dffbbe914cbc1e9cf16
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.52e-07	198	185	9	c5a22846bccff948f90bc1d5fe309907dcd08348
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.52e-07	198	185	9	c49c71b34151d82b8795763bcb633c301c35f659
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.52e-07	198	185	9	4780f0276546962a2fc9f1041cfe49d2919d72b2
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GAS7 BCL6 SLC7A7 CREG1 CREB5 ATP6V0D1 CD14 VCAN SECTM1	1.52e-07	198	185	9	b19a089eb80af3428891f2ff00e53a6e11894fa3
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GAS7 BCL6 SLC7A7 CREG1 CREB5 ATP6V0D1 CD14 VCAN SECTM1	1.52e-07	198	185	9	110f7ebb3e1ec19508d4d2b973e1f64e7bdbb5b5
ToppCell	COVID-19_Mild-Myeloid-Classical_Monocyte\|COVID-19_Mild / Disease group, lineage and cell class	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.52e-07	198	185	9	e78d027a095473af555762a4d542a73f5bb2e166
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.52e-07	198	185	9	06201b34d3e38f22c93b759511f7b376504bac06
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.52e-07	198	185	9	1ca91559fef231896e16180f5e050155c38f7cfa
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FOSL2 GAS7 BCL6 SLC7A7 CREG1 CD14 VCAN SIGLEC1 SECTM1	1.59e-07	199	185	9	cd93e8947bcf3c2d7e6d5bfd70300145fba15f74
ToppCell	control-HLA-DR+_CD83+_Monocyte\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NR4A2 GAS7 BCL6 SLC7A7 CREG1 STAT1 STAT2 SIGLEC1 SECTM1	1.59e-07	199	185	9	f1b370d2869ad29c9d8ff41fdcc486fffa781ee2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FOSL2 GAS7 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.66e-07	200	185	9	933db31e61e08ccf31105b3d3cf85c8d42c8174d
ToppCell	control-Neutrophil\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GAS7 BCL6 SLC7A7 CREG1 CREB5 ATP6V0D1 CD14 VCAN KIF13A	1.66e-07	200	185	9	b5d197472799cc61d7497faed91ac2564ae4930a
ToppCell	severe-CD163+_Monocytes_(Sample_ID1_d7)\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GAS7 BCL6 CREG1 ST14 CREB5 CD14 VCAN SIGLEC1 KIF13A	1.66e-07	200	185	9	a3f22826f3d8f917ff0594bdadd93b60763bcaa2
ToppCell	COVID-19-COVID-19_Mild-Myeloid-CD14+_Monocyte\|COVID-19_Mild / Disease, condition lineage and cell class	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.66e-07	200	185	9	f76d3647f8ab5f7be018b0697c911597198e03f5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FOSL2 GAS7 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.66e-07	200	185	9	c1c6c379b00f63786a1bf9360b2ed1fc7142a3f0
ToppCell	control-HLA-DR-_S100A+_Monocyte\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FOSL2 GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN KIF13A	1.66e-07	200	185	9	9e3e13a68bc1110fa000ec2d80f4c654ddbce17e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FOSL2 GAS7 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.66e-07	200	185	9	d47c7bb0af641a35562a95d55f98bbce70de7168
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9B STAT2 SLC16A5 POP1 HDAC10 NSMAF PLCE1	8.43e-07	123	185	7	a45d6907c041ad3f3218cd46dccfc25d4bd961cb
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH4 MYH13 GAS7 NOX4 CREB5 SVEP1 VCAN ADGRD1	1.10e-06	185	185	8	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	DOK5 PDE3A GAS7 NOX4 CREB5 SVEP1 FREM1 VCAN	1.24e-06	188	185	8	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	PDE3A TENT5A CMYA5 TENM2 CREB5 STOX2 AOPEP USP54	1.35e-06	190	185	8	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE3A CMYA5 TENM2 CREB5 RGS6 PTPRG SCN5A PDZD2	1.35e-06	190	185	8	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	Calu_3-infected-SARSCoV2\|infected / Cell line, Condition and Strain	PRKD2 TENT5A ETV7 ZNFX1 TRIM14 STAT1 STAT2 SECTM1	1.40e-06	191	185	8	2da876d26f37a00dbdf1ee79d724306e8b20f304
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	GPD2 PSMA5 ETV7 DCLRE1B CPOX STAT1 STRIP2 NIPA1	1.46e-06	192	185	8	4e689bca7a242f8482e25f273656e2caba8821c0
ToppCell	RV-08._Macrophage\|RV / Chamber and Cluster_Paper	PARP8 GAS7 TRIM14 WDFY4 CD14 CD163L1 SIGLEC1 NCKAP1L	1.51e-06	193	185	8	12bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TENT5A GAS7 SLC7A7 CD14 VCAN SIGLEC1 ARHGAP45 SECTM1	1.51e-06	193	185	8	4fb020f11fd7aff06952bfeaabc79b2c7b8873f6
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122\|Adult / Lineage, Cell type, age group and donor	GPD2 MYO9B SLC7A7 TRIM14 WDFY4 CD163L1 SIGLEC1 NCKAP1L	1.51e-06	193	185	8	cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958
ToppCell	COVID-19-Heart-Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	PARP8 TRIM14 WDFY4 CD14 CD163L1 SIGLEC1 ARHGAP45 NCKAP1L	1.57e-06	194	185	8	f09675cd472200363c458952f00d2e41990800ee
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TENT5A GAS7 SLC7A7 CD14 VCAN SIGLEC1 ARHGAP45 SECTM1	1.57e-06	194	185	8	885355ebe98e974f841cc59dce3b5228c642c5d0
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231\|Adult / Lineage, Cell type, age group and donor	MYO9B FOSL2 GAS7 CD14 CD163L1 SCARB1 SIGLEC1 NCKAP1L	1.57e-06	194	185	8	800d3d7a9e864d2d6a100a4e4af22f45d5790a8d
ToppCell	LA-08._Macrophage\|World / Chamber and Cluster_Paper	PARP8 GAS7 TRIM14 WDFY4 CD14 CD163L1 SIGLEC1 NCKAP1L	1.57e-06	194	185	8	c1805572bcc11b1cd29083329d7b5911489fb758
ToppCell	Control-Classical_Monocyte-cMono_2\|Control / Disease condition and Cell class	NR4A2 GAS7 SLC7A7 CREG1 CREB5 CD14 VCAN ARHGAP45	1.64e-06	195	185	8	0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PARP8 CNTRL GAS7 WDFY4 CD163L1 SIGLEC1 ARHGAP45 NCKAP1L	1.64e-06	195	185	8	7b6c69df943842b566a596e30bb50dbe80dccc83
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Classical_Monocyte\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SECTM1	1.70e-06	196	185	8	76101d5ebe2a74c0a0a885ec31c3c1847bda8a7b
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SECTM1	1.77e-06	197	185	8	2afc23f7394d9b40bdf06527c5e6b553e1b02dca
ToppCell	COVID-19_Moderate-Classical_Monocyte\|World / disease group, cell group and cell class	GAS7 SLC7A7 CREB5 STAT2 CD14 VCAN SIGLEC1 SECTM1	1.77e-06	197	185	8	16cf3939e700aef1e16159f0652ba2dfad287e7a
ToppCell	severe_COVID-19-Classical_Monocyte\|World / disease group, cell group and cell class (v2)	GAS7 BCL6 SLC7A7 CREG1 ST14 CREB5 CD14 VCAN	1.77e-06	197	185	8	cdffd49db7374d223ded46d636cd4be12d464ea4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9B GAS7 WDFY4 CD14 CD163L1 SIGLEC1 ARHGAP45 NCKAP1L	1.77e-06	197	185	8	d95565652ca318a2298d6918d54ba6367e9560f4
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ETV7 BCL6 SLC7A7 STAT2 CD14 VCAN SIGLEC1 SECTM1	1.77e-06	197	185	8	383d598ce3f8f5fc98bef3300e4cf7b6992aec9c
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GAS7 BCL6 SLC7A7 CREG1 CREB5 ATP6V0D1 CD14 VCAN	1.77e-06	197	185	8	15bcfe6105c0b508811fb9bba0bc4312fea04f4c
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ETV7 BCL6 SLC7A7 STAT2 CD14 VCAN SIGLEC1 SECTM1	1.77e-06	197	185	8	3cc4e56a77f96a43f9b5a24cf1b9524c927ef795
ToppCell	COVID-19_Severe-Classical_Monocyte\|World / disease group, cell group and cell class	GAS7 BCL6 CREG1 CREB5 CD14 VCAN SIGLEC1 KIF13A	1.77e-06	197	185	8	344801997b89bd81d8d5c3c872934de523233a8d
ToppCell	COVID-19_Mild-Classical_Monocyte\|COVID-19_Mild / Disease condition and Cell class	GAS7 BCL6 CREG1 CREB5 CD14 VCAN SIGLEC1 KIF13A	1.83e-06	198	185	8	30ada3de865b6fb2b14196a1cbfd4740c6a57ce3
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ACACA NHSL1 STOX2 PTPRG AOPEP MBD5 KIF13A PDZD2	1.83e-06	198	185	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	COVID-19_Severe-Classical_Monocyte\|COVID-19_Severe / disease group, cell group and cell class	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1	1.83e-06	198	185	8	b88c4c0ed1abf0a28dbe05b04b9bee1073855ba8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9B GAS7 WDFY4 CD14 CD163L1 SIGLEC1 ARHGAP45 NCKAP1L	1.90e-06	199	185	8	04adf46975aa4194ea40c7480f8a517def5d929c
ToppCell	mild_COVID-19_(asymptomatic)-Classical_Monocyte\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	GAS7 BCL6 SLC7A7 CREG1 CD14 VCAN SIGLEC1 SECTM1	1.90e-06	199	185	8	73a98d19871ffbc3c631de330998d42e9afa6da2
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SECTM1	1.90e-06	199	185	8	4fc03377c017209111561789226621d258291481
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GAS7 BCL6 SLC7A7 CREG1 CREB5 CD14 VCAN SECTM1	1.90e-06	199	185	8	0e67257f1ecf90f80e6524d70d38b3733e953b4e
ToppCell	COVID_vent-Myeloid\|COVID_vent / Disease condition, Lineage, Cell class and subclass	GAS7 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.98e-06	200	185	8	621af09aae34226902c03edf556562f3ab35a7d8
ToppCell	COVID_vent-Myeloid-Monocytic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	GAS7 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.98e-06	200	185	8	b0a5bee87700ce38f26f95a6f491da7e27cade51
ToppCell	control-Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GAS7 SLC7A7 CREG1 CREB5 ATP6V0D1 CD14 VCAN KIF13A	1.98e-06	200	185	8	251ca08fab5cc2a4e280db6a6286a9ebaef3e61a
ToppCell	mild-HLA-DR+_CD83+_Monocyte\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GAS7 BCL6 SLC7A7 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.98e-06	200	185	8	8a480f487b52938d00b53bf4b18f067353d34419
ToppCell	severe-CD163+_Monocytes_(Sample_ID1_d7)\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GAS7 SLC7A7 CREG1 ST14 CREB5 CD14 VCAN SIGLEC1	1.98e-06	200	185	8	4943fe826d5fcc3dfeb8b99a7415848f3fecc994
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GAS7 NOX4 CLSTN2 SVEP1 FREM1 PTPRG VCAN ADGRD1	1.98e-06	200	185	8	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	Influenza\|World / Disease, condition lineage and cell class	SGMS2 GAS7 BCL6 SLC7A7 CREB5 ATP6V0D1 CD14 VCAN	1.98e-06	200	185	8	df996c35907a1c9194b9e2ca30e81f520ca067f0
ToppCell	COVID_vent-Myeloid-Monocytic-CD14+_Monocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	GAS7 SLC7A7 CREG1 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.98e-06	200	185	8	e57452b73abb21cb3f645d45523ab93f6bef0243
ToppCell	Hippocampus-Hematopoietic\|Hippocampus / BrainAtlas - Mouse McCarroll V32	TNFRSF17 TRIM14 WDFY4 CD14 TNNI2 ARHGAP45 NCKAP1L	3.32e-06	151	185	7	81b2189afd72658f7e2539b856ba79cd49340215
ToppCell	PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ERCC2 MYO9B NR4A2 BCL6 WDFY4 SRGAP3 TNNI2	4.12e-06	156	185	7	af47a4b17342bdb3cb62d7e2d52a81168e588629
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF21B ACACA SLCO4A1 MDC1 ITSN2 MBD5 KIF13A	4.48e-06	158	185	7	1d78578dc1f8ba43dacdccae1082c0b9d749f64d
ToppCell	(0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte\|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization)	FOSL2 PARP8 NR4A2 GAS7 CREB5 CD14 VCAN	6.45e-06	167	185	7	7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	CMYA5 TRIM14 WDFY4 TENM2 CD163L1 SIGLEC1 NCKAP1L	7.25e-06	170	185	7	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A TENT5A GAS7 SVEP1 ADCYAP1R1 VCAN ADGRD1	7.53e-06	171	185	7	5d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell	PND07-28-samps-Myeloid-Macrophage-CD163+_Macrophage\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	STARD8 TENT5A GAS7 SH2D2A TNFRSF17 CD14 NCKAP1L	7.82e-06	172	185	7	9a659442dc41bd2a4361a7e38a7ee37a39781667
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GAS7 WDFY4 NLGN3 SIGLEC1 TNNI2 ARHGAP45 NCKAP1L	7.82e-06	172	185	7	f6b4754a7e4b3e38030316a0ae00d932bfa87e41
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAND2 BCL6 NLGN3 SRGAP3 HDAC10 TNNI2 NSMAF	8.76e-06	175	185	7	bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	ETV7 ZNFX1 TRIM14 STAT1 STAT2 DNAH9 SECTM1	1.01e-05	179	185	7	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	B3GLCT DCLRE1B FIGN PCDHB16 AOPEP SCUBE3 SLC38A3	1.13e-05	182	185	7	03a5a02acd48f0eb210485348bfe0cd21f486215
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGDCC3 SLCO4A1 ALDH1L1 CMYA5 FREM1 ADGRA1 PLCE1	1.17e-05	183	185	7	25c96df8ea0c7bbedbb7699ee84ad6234d19cba8
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 CPS1 FIGN FREM1 MYO15A DNAH9 PLCE1	1.21e-05	184	185	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 CPS1 FIGN FREM1 MYO15A DNAH9 PLCE1	1.21e-05	184	185	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	normal_Lymph_Node-Myeloid_cells-Monocytes\|normal_Lymph_Node / Location, Cell class and cell subclass	FOSL2 SLC7A7 CREB5 CD14 VCAN SIGLEC1 SECTM1	1.21e-05	184	185	7	3cec28ff076fa53d034428de2bb1a237e0c1568c
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	GAS7 CLSTN2 SVEP1 FREM1 SHROOM4 PTPRG IL6ST	1.21e-05	184	185	7	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 CPS1 FIGN FREM1 MYO15A DNAH9 PLCE1	1.21e-05	184	185	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGDCC3 SLCO4A1 ALDH1L1 CMYA5 FREM1 ADGRA1 PLCE1	1.26e-05	185	185	7	dbbd348714cd16a4948a04648e914b1e71e2a8ef
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGDCC3 SLCO4A1 ALDH1L1 CMYA5 FREM1 ADGRA1 PLCE1	1.26e-05	185	185	7	bea69058afa5aa927fe15c1f8d46460562ec4dd4
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A EXPH5 BCL6 SVEP1 ADCYAP1R1 CD163L1 PLCE1	1.26e-05	185	185	7	0b5a0df58ae2ad8261f40f152775747af4f3937a
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE3A PCDHA5 PCDHA3 FIGN ADGRD1 PLCE1 PDZD2	1.30e-05	186	185	7	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LRRN1 CREB5 SHROOM4 NHSL1 VCAN KIF13A PDZD2	1.35e-05	187	185	7	5b7a1edee602e55d3400dc17dbb6b8aaa26defc0
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LRRN1 CREB5 SHROOM4 NHSL1 VCAN KIF13A PDZD2	1.35e-05	187	185	7	daff7ccd3f1924cf2b34d3aca3eccde245aaf371
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH4 MYH13 GAS7 NOX4 SVEP1 FREM1 ADGRD1	1.39e-05	188	185	7	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CREB5 SH3BP4 SHROOM4 VCAN PHLPP1 USP54 PLXNB1	1.39e-05	188	185	7	60242c29c7f16c94a84685d3bc4ed93a66e70152
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO9B NR4A2 CREG1 CD14 CD163L1 SIGLEC1 NCKAP1L	1.39e-05	188	185	7	cb091912f9b627a78a8793a37df7f1de839f887f
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	PDE3A TENT5A CMYA5 TENM2 STOX2 AOPEP USP54	1.44e-05	189	185	7	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9B GAS7 WDFY4 CD14 CD163L1 SIGLEC1 NCKAP1L	1.49e-05	190	185	7	788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9B GAS7 WDFY4 CD14 CD163L1 SIGLEC1 NCKAP1L	1.55e-05	191	185	7	baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDHD3 NOX4 SLC7A7 CREB5 STOX2 FGGY PDZD2	1.55e-05	191	185	7	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDHD3 NOX4 SLC7A7 CREB5 STOX2 FGGY PDZD2	1.55e-05	191	185	7	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TENT5A NR4A2 BCL6 SVEP1 ADCYAP1R1 VSIG10L2 ADGRD1	1.55e-05	191	185	7	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	LV-08._Macrophage\|LV / Chamber and Cluster_Paper	PARP8 GAS7 TRIM14 WDFY4 CD163L1 SIGLEC1 NCKAP1L	1.60e-05	192	185	7	7be12d580aaf2f2f1562203fcad3a44639b8c5a6
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	PARP8 GAS7 TRIM14 WDFY4 CD163L1 SIGLEC1 NCKAP1L	1.60e-05	192	185	7	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TENT5A NR4A2 BCL6 SVEP1 ADCYAP1R1 VSIG10L2 ADGRD1	1.65e-05	193	185	7	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TENT5A SLC7A7 ST14 ATP6V0D1 CD14 VCAN SIGLEC1	1.65e-05	193	185	7	93ba635ed69fec9286fe7636b9d258f3d93a22c3
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TENT5A SLC7A7 ST14 ATP6V0D1 CD14 VCAN SIGLEC1	1.65e-05	193	185	7	6dfdeb793cb5ad6412b6f808b5687a4e74b6ec65
Computational	Genes in the cancer module 123.	HIVEP1 ERCC6 JADE3 FOSL2 NR4A2 GAS7 BCL6 CREG1 STAT1 ADCYAP1R1 STAT2 OVOL1	6.56e-06	247	108	12	MODULE_123
Drug	purealin	MYH1 MYH4 MYH13 MYO9B AFDN MYO15A DNAH9	4.26e-07	58	184	7	CID006419303
Drug	Picrotoxinin [17617-45-7]; Up 200; 13.6uM; HL60; HT_HG-U133A	ZNF219 BEST2 ALDH1L1 TNFRSF17 SLC7A7 MAP3K6 CREB5 TRIM3 SLC16A5 MEGF8 ALOXE3	6.33e-07	197	184	11	2161_UP
Drug	[(E)-[amino-[methyl(nitroso)amino]methylidene]amino]-hydroxy-oxoazanium	ERCC2 SLC38A5 GC CHEK1 CCNB1 NLGN3 SLC38A3	3.00e-06	77	184	7	CID009572782
Drug	formycin triphosphate	MYH1 MYH4 MYH13 MYO9B AFDN MYO15A	3.42e-06	51	184	6	CID000122274
Drug	blebbistatin	MYH1 MYH4 MYH13 ACTRT3 MYO9B RHBDL1 AFDN MYO15A	4.72e-06	116	184	8	CID003476986
Drug	Solasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ERCC2 MYO9B CPS1 RTN2 PLA2G4C SLC16A5 MEGF8 SRGAP3 CIZ1 AFDN	5.08e-06	198	184	10	6025_UP
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A	DOK5 ATG10 TENT5A FOSL2 ETV7 NR4A2 ALDH1L1 BCL6 STAT2	1.58e-05	179	184	9	2656_UP
Drug	S-(-)-Etomoxir	MYH1 MYH4 ACACA MYH13 MYO9B AFDN MYO15A	1.71e-05	100	184	7	CID000060765
Drug	compound 21	PDE3A ACACA GC CHEK1 ST14	1.71e-05	40	184	5	CID005312128
Drug	radicicol; Up 200; 0.1uM; MCF7; HG-U133A	PRKD2 FLNB OGT FOSL2 CPOX TRIM14 PLAA FGGY PLXNB1	2.64e-05	191	184	9	489_UP
Drug	Vitamin K2 [11032-49-8]; Up 200; 9uM; MCF7; HT_HG-U133A	KIF21B FOSL2 NR4A2 GAS7 DNASE2B OVOL1 SLC16A5 ALOXE3 MUC2	2.75e-05	192	184	9	4356_UP
Drug	iodomethylate	CYP2B6 SLC38A5 CLSTN2 CRAMP1	3.24e-05	23	184	4	CID000123359
Drug	CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A	MYO9B RTN2 CREB5 TRIM3 GHRHR ARHGAP1 SRGAP3 SCARB1 ALOXE3	3.36e-05	197	184	9	3825_DN
Drug	Metrizamide [31112-62-6]; Up 200; 5uM; MCF7; HT_HG-U133A	KIF21B GAS7 PCDHA3 SH2D2A TRIM3 STAT2 ARHGAP1 MEGF8 VCAN	3.36e-05	197	184	9	4156_UP
Drug	Bezafibrate [41859-67-0]; Up 200; 11uM; MCF7; HT_HG-U133A	CYP2B6 STARD8 ETV7 ALDH1L1 SVEP1 STAT2 PLA2G4C SCARB1 SECTM1	3.36e-05	197	184	9	2630_UP
Drug	Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ERCC2 MYO9B GAS7 CPS1 TRIM3 NSD3 SRGAP3 VCAN FUT3	3.36e-05	197	184	9	2860_UP
Drug	Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; HL60; HG-U133A	FLNB NR4A2 SLCO4A1 CPOX NUDT13 FOCAD PLAA SGPL1 CIZ1	3.36e-05	197	184	9	1789_DN
Drug	Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A	CYP2B6 NR4A2 PCDHA5 ALDH1L1 SLC7A7 SLC16A5 DEPDC5 IL6ST PDZD2	3.50e-05	198	184	9	4158_UP
Drug	Procarbazine hydrochloride [366-70-1]; Up 200; 15.6uM; MCF7; HT_HG-U133A	DOK5 ETV7 TNFRSF17 TRIM14 SVEP1 TRIM3 NSD3 SLC16A5 AFDN	3.50e-05	198	184	9	3533_UP
Drug	Epitiostanol [2363-58-8]; Up 200; 13uM; PC3; HT_HG-U133A	SUSD4 ATG10 CAND2 CNTRL NR4A2 GAS7 PCDHA5 STAT1 SCARB1	3.64e-05	199	184	9	4204_UP
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; MCF7; HT_HG-U133A	KIF21B ATG10 PCDHA5 TRIM3 STAT2 NSD3 GHRHR MUC2 SECTM1	3.64e-05	199	184	9	5449_UP
Drug	NSC339663	MYH1 MYH4 MYH13 ACTRT3 MYO9B PSMA5 TEX101 ITSN2 AFDN MYO15A	3.83e-05	250	184	10	CID000003892
Drug	B0683	MYH1 MYH4 MYH13 ACTRT3 MYO9B AFDN MYO15A	4.71e-05	117	184	7	CID006398969
Drug	eye gene	PRKD2 MYH1 MYH4 PDE3A ACACA MYH13 ACTRT3 MYO9B AFDN ALOXE3 MYO15A PLCE1	4.93e-05	369	184	12	CID000004782
Drug	oxovanadium	MYH1 MYH4 MYH13 ATP6V0D1 VCAN FUT3 UPP2	5.54e-05	120	184	7	CID000024411
Drug	9,12,15-octadecatrienoic acid	PRKD2 SLC38A5 PLA2G4C QPRT SCARB1 ALOXE3 SIGLEC1 SLC38A3	6.63e-05	167	184	8	CID000000860
Drug	trifluoperazine	PRKD2 MYH1 MYH4 ACACA MYH13 ACTRT3 MYO9B AFDN ALOXE3 MYO15A TNNI2	6.97e-05	324	184	11	CID000005566
Drug	hydroxyl radicals	GPD2 KIF21B PRKD2 CYP2B6 PSMA5 SLC38A5 NOX4 GC CLSTN2 ALDH1L1 CPOX CPS1 TNFRSF17 CCNB1 USP6 ATP6V0D1 PLA2G4C PTPRG QPRT PHLPP1 FUT3 UPP2 ALDH5A1 SLC38A3 NSMAF	8.28e-05	1341	184	25	CID000000961
Drug	Air Pollutants, Occupational	ERCC2 HIVEP1 PSMA5 NR4A2 PCDHA3 TNFRSF17 STAT1 STAT2 NHSL1 ARHGAP1 RGS6 CD14 CLN5 ITSN2 GPN3 SECTM1 NCKAP1L	8.73e-05	725	184	17	ctd:D000395
Drug	Zidovudine	OGT ACACA SLCO4A1 SLC38A5 CHEK1 SLC7A7 SLC22A17 STAT1 STAT2 CCNB1 RGS6 SIGLEC1 TNNI2 SLC38A3	9.18e-05	521	184	14	ctd:D015215
Drug	SAHA; Down 200; 10uM; HL60; HT_HG-U133A	FOSL2 PARP8 CD14 CTCF VCAN KBTBD11 ARHGAP45 NSMAF	9.20e-05	175	184	8	1161_DN
Drug	2BrP	ST14 STAT1 STAT2 CD14 CRAMP1 IL6ST	1.09e-04	93	184	6	CID006540269
Drug	isoproterenol	PRKD2 MYH1 MYH4 PDE3A MYH13 ACTRT3 MYO9B EXPH5 NOX4 CPOX VCAN SCN5A AFDN FUT3 MYO15A TNNI2	1.13e-04	669	184	16	CID000003779
Drug	1,1-dichloroethylene	CYP2B6 GC CLSTN2 STAT2 DNAH9	1.24e-04	60	184	5	CID000006366
Drug	AC1NRBPQ	MYH1 MYH4 MYH13 ACTRT3 PHLPP1 AFDN TNNI2	1.28e-04	137	184	7	CID005288569
Drug	Vanadates	FLNB ATG10 ACACA EXPH5 TENT5A PARP8 CNTRL PCDHB15 SLCO4A1 CHEK1 FIGN TRIM14 TENM2 CCNB1 STOX2 PTPRG CLN5 PRKAA1 NIPA1 MAP3K21 KIF13A WDR17 ALDH5A1 PLCE1	1.38e-04	1302	184	24	ctd:D014638
Drug	G-F-F	PDE3A PSMA5 GC	1.40e-04	13	184	3	CID015942678
Drug	bromine atom	FLNB SLC38A5 GC SIGLEC1	1.41e-04	33	184	4	CID005360770
Drug	MgCl2	MYH1 MYH4 MYH13 ACTRT3 MYO9B CPOX POP1 AFDN MYO15A TNNI2 DNAH9	1.52e-04	354	184	11	CID000024584
Drug	Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	NR4A2 PCDHA5 RTN2 SVEP1 GHRHR PTPRG SCARB1 AFDN	1.68e-04	191	184	8	4190_UP
Drug	Betamethasone [378-44-9]; Up 200; 10.2uM; PC3; HT_HG-U133A	ALDH1L1 BCL6 STAT2 DNASE2B SCARB1 CIZ1 AFDN FUT3	1.74e-04	192	184	8	6728_UP
Drug	estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	GPD2 ERCC2 NR4A2 TRIM3 GHRHR SLC16A5 SCARB1 SECTM1	1.74e-04	192	184	8	5955_UP
Drug	hydrazine	LRRN1 NOX4 ALDH1L1 BCL6 STAT1 CCNB1 HDAC10 UPP2	1.81e-04	193	184	8	ctd:C029424
Drug	NSC625381	MYH1 MYH4 GC CTCF QPRT AADAT IL6ST	1.82e-04	145	184	7	CID000002592
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A	FOSL2 CLSTN2 RTN2 SLC22A17 TRIM3 OVOL1 PLA2G4C ARHGAP45	1.87e-04	194	184	8	4738_DN
Drug	F0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A	KIF21B FOSL2 GAS7 TRIM14 SLC22A17 PLAA SCARB1 SIGLEC1	1.87e-04	194	184	8	6424_UP
Drug	t-butylbromide	SLC38A5 SLC38A3	1.94e-04	3	184	2	CID000010485
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ERCC2 MYO9B TRIM3 NSD3 KBTBD11 C8orf44 DEPDC5 SECTM1	1.94e-04	195	184	8	3893_DN
Drug	Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	MYO9B NR4A2 TNFRSF17 TRIM3 GHRHR VCAN ALOXE3 SIGLEC1	1.94e-04	195	184	8	5669_UP
Drug	Ethionamide [536-33-4]; Down 200; 24uM; MCF7; HT_HG-U133A	ERCC6 CNTRL GAS7 ALDH1L1 PLA2G4C MEGF8 ALDH5A1 PDZD2	1.94e-04	195	184	8	4418_DN
Drug	Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A	DOK5 ATG10 RHBDL1 GAS7 PCDHA5 ALDH1L1 RGS6 SECTM1	2.01e-04	196	184	8	4421_UP
Drug	Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A	BEST2 BCL6 TNFRSF17 SVEP1 VCAN CIZ1 AFDN DEPDC5	2.01e-04	196	184	8	4409_UP
Drug	3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A	BEST2 CLSTN2 TRIM14 NSD3 MEGF8 SCARB1 DEPDC5 MUC2	2.01e-04	196	184	8	6367_DN
Drug	Conessine [546-06-5]; Up 200; 11.2uM; PC3; HT_HG-U133A	KIF21B ATG10 NR4A2 NSD3 SRGAP3 AFDN ALOXE3 DEPDC5	2.01e-04	196	184	8	4191_UP
Drug	Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A	MYO9B GAS7 TRIM3 RGS6 SCN5A ALOXE3 PLXNB1 SECTM1	2.01e-04	196	184	8	4420_UP
Drug	Pentetic acid [67-43-6]; Up 200; 10.2uM; PC3; HT_HG-U133A	BEST2 NR4A2 GAS7 TRIM3 AFDN ALOXE3 KIF13A IL6ST	2.01e-04	196	184	8	4669_UP
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A	ERCC2 ATG10 PCDHA5 TNFRSF17 SLC16A5 C8orf44 DEPDC5 SECTM1	2.01e-04	196	184	8	2250_UP
Drug	genistein; Up 200; 10uM; HL60; HT_HG-U133A	GPD2 CYP2B6 FOSL2 ETV7 NR4A2 PLA2G4C SCN5A SIGLEC1	2.01e-04	196	184	8	6194_UP
Drug	POPC	PRKD2 PSMA5 SLC38A5 CPOX SLC7A7 PLA2G4C SCARB1 ALOXE3 SLC38A3 PLCE1	2.03e-04	306	184	10	CID000065167
Drug	Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A	MYO9B FOSL2 NR4A2 GAS7 TRIM14 RTN2 SVEP1 IL6ST	2.08e-04	197	184	8	6204_UP
Drug	sulindac sulfone; Up 200; 50uM; MCF7; HG-U133A	SUSD4 OGT STARD8 GAS7 BCL6 GHRHR VCAN DLEC1	2.08e-04	197	184	8	314_UP
Drug	Morantel tartrate [26155-31-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	NR4A2 SLC22A17 STAT1 GHRHR PLA2G4C KBTBD11 KIF13A IL6ST	2.08e-04	197	184	8	1676_UP
Drug	Propidium iodide [25535-16-4]; Up 200; 6uM; PC3; HT_HG-U133A	ATG10 MYO9B FOSL2 ETV7 GAS7 SLC7A7 CIZ1 AFDN	2.08e-04	197	184	8	5803_UP
Drug	Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; PC3; HT_HG-U133A	CAND2 NR4A2 PCDHA5 SH2D2A OVOL1 PTPRG ALOXE3 KIF13A	2.08e-04	197	184	8	4199_UP
Drug	Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A	KIF21B PARP8 RTN2 TRIM3 SRGAP3 ALOXE3 PLXNB1 PDZD2	2.08e-04	197	184	8	6475_UP
Drug	sulfasalazine; Up 200; 100uM; MCF7; HG-U133A	GAS7 SH2D2A BCL6 SLC7A7 TMEM127 GHRHR OVOL1 MUC2	2.08e-04	197	184	8	204_UP
Drug	Pyrilamine maleate [59-33-6]; Up 200; 10uM; MCF7; HT_HG-U133A	DOK5 STARD8 PARP8 BCL6 CPS1 ALOXE3 FUT3 MUC2	2.08e-04	197	184	8	3184_UP
Drug	Triflusal [322-79-2]; Down 200; 16.2uM; HL60; HG-U133A	NR4A2 RIOK3 FOCAD CER1 ARHGAP1 VCAN ITSN2 PHLPP1	2.08e-04	197	184	8	1717_DN
Drug	CGX 0596987; Up 200; 20uM; MCF7; HT_HG-U133A	ERCC2 OGT FOSL2 GAS7 MEGF8 SCN5A FUT3 SECTM1	2.08e-04	197	184	8	6412_UP
Drug	Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	ZNF219 HIVEP1 BCL6 PLAA SCARB1 FGGY IL6ST SECTM1	2.15e-04	198	184	8	6256_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; PC3; HT_HG-U133A	PARP8 ETV7 ALDH1L1 TRIM3 STAT2 PTPRG ALOXE3 DEPDC5	2.15e-04	198	184	8	3755_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A_EA	NR4A2 MAP3K6 STAT1 TRIM3 CLN5 SCARB1 PRKAA1 PLXNB1	2.15e-04	198	184	8	1020_DN
Drug	Azathioprine [446-86-6]; Up 200; 14.4uM; PC3; HG-U133A	OGT MYO9B RIOK3 CPOX SRGAP3 CIZ1 GPN3 PLCE1	2.15e-04	198	184	8	1945_UP
Drug	Bezafibrate [41859-67-0]; Up 200; 11uM; MCF7; HT_HG-U133A	DOK5 NR4A2 ALDH1L1 TRIM3 GHRHR OVOL1 SRGAP3 DEPDC5	2.15e-04	198	184	8	4999_UP
Drug	Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; PC3; HG-U133A	ATG10 GAS7 RIOK3 GHRHR ARHGAP1 CIZ1 MUC2 GPN3	2.15e-04	198	184	8	1940_UP
Drug	Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	ERCC6 GAS7 SH2D2A BCL6 TNFRSF17 GHRHR OVOL1 DNAH9	2.15e-04	198	184	8	2874_UP
Drug	Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; PC3; HT_HG-U133A	KIF21B PARP8 NR4A2 GAS7 RTN2 VCAN ALOXE3 SIGLEC1	2.15e-04	198	184	8	6604_UP
Drug	13-HpOTrE	SLC38A5 ALOXE3 SLC38A3	2.20e-04	15	184	3	CID005282866
Drug	Smoke	LRRN1 ACTRT3 ETV7 RIOK3 CPOX SLC7A7 CREG1 ST14 SVEP1 STAT1 USP6 OVOL1 CD14 CD163L1 SCARB1 VCAN WDR17 PLXNB1 PDZD2	2.21e-04	937	184	19	ctd:D012906
Drug	N-acetoxy-2-acetylaminofluorene	ERCC2 ERCC6 NR4A2 RAD9A	2.21e-04	37	184	4	CID000022469
Drug	Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; MCF7; HT_HG-U133A	ETV7 GAS7 CLSTN2 ALDH1L1 SLC7A7 SVEP1 TRIM3 SECTM1	2.23e-04	199	184	8	5986_UP
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	ATG10 SVEP1 STAT2 NSD3 SRGAP3 VCAN KBTBD11 IL6ST	2.23e-04	199	184	8	4316_DN
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A	KIF21B ZNF219 ATG10 GC TNFRSF17 CREB5 VCAN MYO15A	2.23e-04	199	184	8	5079_UP
Drug	Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A	MYO9B EXPH5 GAS7 TRIM14 SVEP1 NSD3 MYO15A KIF13A	2.23e-04	199	184	8	5995_UP
Drug	Pipemidic acid [51940-44-4]; Up 200; 13.2uM; PC3; HT_HG-U133A	NR4A2 GAS7 ALDH1L1 TRIM3 GHRHR SCARB1 C8orf44 FUT3	2.23e-04	199	184	8	6752_UP
Drug	Flucytosine [2022-85-7]; Up 200; 31uM; PC3; HT_HG-U133A	FOSL2 PCDHA5 TRIM3 SLC16A5 VCAN CIZ1 DEPDC5 MUC2	2.23e-04	199	184	8	6690_UP
Drug	tetraethylenepentamine pentahydrochloride; Down 200; 100uM; ssMCF7; HG-U133A	HDHD3 ERCC2 OGT TRIM14 TMEM127 OVOL1 SIGLEC1 GPN3	2.23e-04	199	184	8	498_DN
Drug	Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; HL60; HT_HG-U133A	ETV7 TNFRSF17 ST14 GHRHR PLA2G4C SLC16A5 SCN5A IL6ST	2.23e-04	199	184	8	3089_UP
Drug	SC-560; Up 200; 10uM; MCF7; HT_HG-U133A	GPD2 NR4A2 GAS7 RTN2 GHRHR CLN5 PHLPP1 SECTM1	2.23e-04	199	184	8	6870_UP
Drug	Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; HL60; HT_HG-U133A	DOK5 ZNF219 ERCC6 SH2D2A CPS1 ST14 TRIM3 SGPL1	2.30e-04	200	184	8	2542_UP
Drug	PHA-00851261E [724719-49-7]; Up 200; 10uM; PC3; HT_HG-U133A	FOSL2 PCDHA5 CREB5 TRIM3 ITSN2 AFDN ALOXE3 MUC2	2.30e-04	200	184	8	3773_UP
Drug	dimethyl sulfate	ERCC6 SLC38A5 USP6 CTCF SGPL1 SLC38A3	2.36e-04	107	184	6	CID000006497
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH4 MYH13 TNNI2	1.70e-06	15	179	4	DOID:0050646 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH4 MYH13	2.55e-05	10	179	3	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH4 MYH13	2.55e-05	10	179	3	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH4 MYH13	2.55e-05	10	179	3	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH4 MYH13	2.55e-05	10	179	3	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH4 MYH13	2.55e-05	10	179	3	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH4 MYH13	2.55e-05	10	179	3	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH4 MYH13	2.55e-05	10	179	3	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH4 MYH13	2.55e-05	10	179	3	DOID:0080326 (implicated_via_orthology)
Disease	1,5 anhydroglucitol measurement	PCDHA8 PCDHA5 PCDHA3 PCDHA1	2.76e-05	29	179	4	EFO_0008009
Disease	Malignant neoplasm of breast	GPI MYH1 FLNB ATG10 STARD8 ERCC6 PCDHB15 CHEK1 SLC7A7 MAP3K6 STAT1 SRGAP3 PRKAA1 ITSN2 POP1 DLEC1 USP54 DNAH9 PLXNB1	3.12e-05	1074	179	19	C0006142
Disease	spontaneous preterm birth	B3GLCT GC SVEP1 NHSL1 PTPRG DLEC1	3.60e-05	101	179	6	EFO_0006917
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH4 MYH13	4.64e-05	12	179	3	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH4 MYH13	4.64e-05	12	179	3	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH4 MYH13	6.00e-05	13	179	3	DOID:397 (implicated_via_orthology)
Disease	pulse pressure measurement	FLNB PDE3A B3GLCT FOSL2 CNTRL NOX4 PCDHA8 PCDHA5 PCDHA3 PCDHA1 FIGN TMEM127 SLC22A17 CREB5 SVEP1 NSD3 MEGF8 DLEC1 MBD5 FGGY PLCE1	1.16e-04	1392	179	21	EFO_0005763
Disease	cardiovascular disease	B3GLCT MYO9B FOSL2 DCLRE1B FIGN SVEP1 FREM1 CER1 OVOL1 NPC1L1 PLCE1	1.18e-04	457	179	11	EFO_0000319
Disease	visceral adipose tissue measurement, body mass index	PCDHA8 PCDHA5 PCDHA3 PCDHA1 CLSTN2	1.92e-04	87	179	5	EFO_0004340, EFO_0004765
Disease	myopathy (implicated_via_orthology)	MYH1 FLNB MYH4 MYH13	2.07e-04	48	179	4	DOID:423 (implicated_via_orthology)
Disease	Eczema	CD14 IL6ST	2.18e-04	4	179	2	C0013595
Disease	Chediak-Higashi syndrome (implicated_via_orthology)	WDFY4 NSMAF	2.18e-04	4	179	2	DOID:2935 (implicated_via_orthology)
Disease	Cerebrooculofacioskeletal Syndrome 1	ERCC2 ERCC6	2.18e-04	4	179	2	C0220722
Disease	neutrophil count, basophil count	PCDHA8 GC PCDHA5 PCDHA3 PCDHA1 CREB5 ITSN2	4.55e-04	224	179	7	EFO_0004833, EFO_0005090
Disease	Neurologic Deficits	SGPL1 ALDH5A1	5.40e-04	6	179	2	C0521654
Disease	Cockayne syndrome (implicated_via_orthology)	ERCC2 ERCC6	5.40e-04	6	179	2	DOID:2962 (implicated_via_orthology)
Disease	stimulant use measurement	HIVEP1 CPS1 DLEC1	6.43e-04	28	179	3	EFO_0600076
Disease	cardiomyopathy (implicated_via_orthology)	MYH1 MYH4 MYH13 TNNI2	9.27e-04	71	179	4	DOID:0050700 (implicated_via_orthology)
Disease	electroencephalogram measurement	CMYA5 SLC7A7 SH3BP4 FOCAD	1.08e-03	74	179	4	EFO_0004357
Disease	2R,3R-dihydroxybutyrate measurement	CPS1 CROCC2	1.28e-03	9	179	2	EFO_0800314
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH4 MYH13 TNNI2	1.45e-03	80	179	4	DOID:12930 (implicated_via_orthology)
Disease	post-traumatic stress disorder symptom measurement	PCDHA8 PCDHA5 PCDHA3 PCDHA1	1.58e-03	82	179	4	EFO_0008535
Disease	celiac disease (is_implicated_in)	MYO9B CD14	1.59e-03	10	179	2	DOID:10608 (is_implicated_in)
Disease	age of onset of depressive disorder, wellbeing measurement	CMYA5 ARHGAP45	1.59e-03	10	179	2	EFO_0007869, OBA_2040166
Disease	ascending aortic diameter	FLNB FIGN MBD5 FGGY PLCE1	1.67e-03	140	179	5	EFO_0021787
Disease	total blood protein measurement	SLC38A5 RIOK3 CPS1 TNFRSF17 SCARB1 AFDN SIGLEC1 ARHGAP45 PLCE1	1.76e-03	449	179	9	EFO_0004536
Disease	neutrophil count	FLNB HIVEP1 TENT5A PARP8 PSMA5 PCDHA8 RIOK3 GC PCDHA5 PCDHA3 PCDHA1 DCLRE1B CPS1 CREB5 ITSN2 SCUBE3 ARHGAP45 FGGY	1.93e-03	1382	179	18	EFO_0004833
Disease	N-acetylputrescine measurement	HDAC10 SLC38A3	2.32e-03	12	179	2	EFO_0800127
Disease	candidiasis (implicated_via_orthology)	DHX36 PRKD2 FUT3	2.42e-03	44	179	3	DOID:1508 (implicated_via_orthology)
Disease	glucagon measurement	B3GLCT HIVEP1 BCL6 ALOXE3 NSMAF	2.54e-03	154	179	5	EFO_0008463
Disease	Paroxysmal atrial fibrillation	CAND2 CREB5 AOPEP SCN5A MBD5	2.68e-03	156	179	5	C0235480
Disease	familial atrial fibrillation	CAND2 CREB5 AOPEP SCN5A MBD5	2.68e-03	156	179	5	C3468561
Disease	Persistent atrial fibrillation	CAND2 CREB5 AOPEP SCN5A MBD5	2.68e-03	156	179	5	C2585653
Disease	homocysteine measurement	NOX4 ALDH1L1 CPS1	2.75e-03	46	179	3	EFO_0004578
Disease	Atrial Fibrillation	CAND2 CREB5 AOPEP SCN5A MBD5	2.99e-03	160	179	5	C0004238
Disease	congenital left-sided heart lesions	ADCYAP1R1 GHRHR UPP2	3.11e-03	48	179	3	EFO_0005938
Disease	Kidney Failure, Chronic	CYP2B6 NOX4 SCARB1	3.11e-03	48	179	3	C0022661
Disease	N-acetylglycine measurement	ALDH1L1 CPS1	3.17e-03	14	179	2	EFO_0021002
Disease	cholestasis (biomarker_via_orthology)	ALDH1L1 CD14 PRKAA1	3.30e-03	49	179	3	DOID:13580 (biomarker_via_orthology)
Disease	P wave duration	CAND2 SCN5A	3.65e-03	15	179	2	EFO_0005094
Disease	Colorectal Carcinoma	ERCC2 STARD8 ERCC6 ACACA PARP8 NR4A2 CLSTN2 ALDH1L1 ITPRID1 GHRHR IL6ST	3.87e-03	702	179	11	C0009402
Disease	susceptibility to rubella infection measurement	AOPEP KIF13A PDZD2	3.90e-03	52	179	3	EFO_0008418
Disease	amygdala volume change measurement	PARP8 FGGY	4.15e-03	16	179	2	EFO_0021490
Disease	phosphatidylcholine 38:6 measurement	CPOX DEPDC5	4.15e-03	16	179	2	EFO_0010388
Disease	depressive symptom measurement	HIVEP1 NR4A2 PCDHA5 PCDHA3 PCDHA1 TENM2 ADCYAP1R1 PTPRG	4.64e-03	426	179	8	EFO_0007006
Disease	response to phenylephrine	CLSTN2 TNFRSF17	4.69e-03	17	179	2	EFO_0010152
Disease	brain aneurysm	RGS6 CD163L1 PLCE1 PDZD2	5.05e-03	113	179	4	EFO_0003870
Disease	hippocampal tail volume	ITPRID1 STOX2	5.85e-03	19	179	2	EFO_0009398
Disease	unipolar depression, response to bupropion, mood disorder	GPI STOX2	5.85e-03	19	179	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	sensorineural hearing loss (implicated_via_orthology)	SCARB1 DNAH9	5.85e-03	19	179	2	DOID:10003 (implicated_via_orthology)
Disease	stroke, major depressive disorder	NR4A2 PTPRG	5.85e-03	19	179	2	EFO_0000712, MONDO_0002009

Protein segments in the cluster

Peptide	Gene	Start	Entry
SAARMPETGPVLVHC	PTPRG	1046	P23470
VIQHMPVSCAGGQLP	C2orf16	1011	Q68DN1
CIARVMLPPGAQHSD	AFDN	296	P55196
PLPDALMCVVAGTVH	BEST2	101	Q8NFU1
HYPPSQGQMDLCVTS	AADAT	101	Q8N5Z0
VDPLNVDHFSCTPLM	CAMTA1	1101	Q9Y6Y1
FSIPFIPMGVLHCNV	CNTRL	1301	Q7Z7A1
FTVHLGPRPVVMLCG	CYP2B6	66	P20813
PPLIHCSGEMLKFTE	CAGE1	191	Q8TC20
PIPTLSLMGGCREHF	C8orf44	16	Q96CB5
MCFSGLGIPVTHSPL	B3GLCT	426	Q6Y288
LSGKVSLPCHFSTMP	VCAN	36	P13611
EPMICHTLPLPEGFQ	CTCF	151	P49711
GISFSQPTCPDHMLL	CHEK1	341	O14757
EPGTTPCQVMAVLLH	ADGRD1	626	Q6QNK2
EALFSPCHMNLEAPG	ACTRT3	256	Q9BYD9
THTLACCTQGDPFPM	ADGRA1	466	Q86SQ6
CVVEFQFMLPTSHPN	ACACA	1176	Q13085
MPEPCHIPVTNARTF	AOPEP	76	Q8N6M6
FVLHPCKTNEFMTPV	ATG10	161	Q9H0Y0
MTVLGAPPCIHGNTV	CD163L1	981	Q9NR16
PAKFTTMHLPLNCTE	CER1	211	O95813
SMPLFPSIHLETCDG	CLSTN2	276	Q9H4D0
MNGVLIPHTPIAVDF	DCLRE1B	1	Q9H816
LGPTVIVCPTTVMHQ	ERCC6	566	Q03468
SPVLMAQGPSEKTHC	RAB19	201	A4D1S5
SLQAVFDPASCPHML	RAD9A	131	Q99638
DVHRPVPGCVNTTEM	RGS6	201	P49758
RATPAFHPVCQVIAM	ITSN2	1121	Q9NZM3
MHSFLVVGPQALDPV	HDHD3	206	Q9BSH5
KCSENATMTLPGIHP	NOL11	626	Q9H8H0
PGCSQRFPTEDHLMI	CREB5	21	Q02930
LVCMGEQPLHAVPLF	DEPDC5	366	O75140
LCQEAVVGPLHAMPA	FIGN	696	Q5HY92
VCDEPHVFQNGPMLR	PARP8	511	Q8N3A8
HVFQNGPMLRPTVCE	PARP8	516	Q8N3A8
ANGQVTCSLMPHVPF	PCDHA8	381	Q9Y5H6
GNPPMSDHCTVLLEI	PCDHA3	326	Q9Y5H8
LCHSASQSLPAMPVP	FOXB2	351	Q5VYV0
AAICQPSAGVHIVMP	GPD2	306	P43304
QTAPLPVHFQMLCES	ARHGAP45	516	Q92619
TAMFTCQAQGEPPPH	IGDCC3	346	Q8IVU1
AFMLTPPQELGPSHC	MDC1	721	Q14676
SCSKIHPGMAPRTVF	ITPRID1	971	Q6ZRS4
CHFKEPAFGMLTVPL	MYO15A	2056	Q9UKN7
GVNPVMLHCISSLPS	ALOXE3	281	Q9BYJ1
CHISLFQIPLPEDGM	KIAA1109	4636	Q2LD37
PHMVESQVCPLIGEI	BPIFA3	201	Q9BQP9
GCTVIEMATGRPPFH	MAP3K6	836	O95382
SENIMSPACVVSPHA	NHSL1	396	Q5SYE7
VPMGKNSHCVRFVPQ	FLNB	2146	O75369
CDAGPMVASHQSPLV	PLXNB1	666	O43157
CQPRPTHFVALMVTE	LENG9	316	Q96B70
PITMSLPFCASHQIN	OR2T6	161	Q8NHC8
HVPCNTSCSPGFELM	MUC2	4966	Q02817
FHMAVLSEPDRGCPT	PDZD2	2001	O15018
TSLPCIPREQLMGHS	PDE3A	311	Q14432
APLQCVSMAEGHTKP	KIF21B	1296	O75037
PMQDIGPHCRDVQFT	FREM1	736	Q5H8C1
PLTVAGIPSMHICLD	INTS2	1026	Q9H0H0
CFSHSLLNVSPMPVE	MEGF8	2036	Q7Z7M0
GHYMTLPVSPDQLPC	PMS2P11	101	Q13670
REVFSSHCPFLMGPI	NCKAP1L	926	P55160
RHPGIVNLECMFETP	PRKD2	606	Q9BZL6
PTIANPILHFSCMDA	ERCC2	426	P18074
TQLTPHFGTPNVCSM	EXPH5	571	Q8NEV8
VYLMPSPNLDVHGEC	DOK5	141	Q9P104
HQGTKMIPCDFLIPV	GPI	396	P06744
CIIPNETKTPGAMEH	MYH1	676	P12882
LPQFCGPHIDVISMG	QPRT	256	Q15274
PQLFHMDPSGTFVQC	PSMA5	151	P28066
NGQVTCSLMPHVPFK	PCDHA5	381	Q9Y5H7
CGPTEPCIMHFQVLL	PCDHB15	96	Q9Y5E8
QSICFLGRMLHTPPV	PRSS54	146	Q6PEW0
PFPSGSLMIACHATV	NUDT13	266	Q86X67
MSPGICIQLVAAPHS	OR8U9	136	P0C7N5
VSALENHPFTLTMCP	NOX4	346	Q9NPH5
PCVVAQLPSEDMGHL	OVOL1	76	O14753
PAHVGEMVLVSCPEL	ADCYAP1R1	66	P41586
ANGQVTCSLMPHVPF	PCDHA1	381	Q9Y5I3
SVCGGRFHPQPMIIS	NPIPB11	711	E5RHQ5
VAAVMVASCPNHPSR	NPC1L1	1311	Q9UHC9
PHTMICVPAKEDFLQ	POP1	871	Q99575
CGPTEPCILHFQVLM	PCDHB16	96	Q9NRJ7
CPQNIHTAVPEVMLP	NLGN3	106	Q9NZ94
GPVVMHFPLFNIDAC	PLA2G4C	461	Q9UP65
KALRMCHPSIEGFTP	CPS1	811	P31327
MVHFPPSQIAAGAFC	CCNB1	336	P14635
GLMAALCPHKFPAIQ	CD14	211	P08571
PEGQMQATPECFAHL	HDAC10	271	Q969S8
MNAVAASLPPRVAHC	FASTKD5	411	Q7L8L6
IPACDFQATHPVMDL	IL6ST	416	P40189
DCPGQIELYTHLPVM	GPN3	106	Q9UHW5
CSIPATFHQELIHMP	DNASE2B	196	Q8WZ79
AMPPLGTHVQARCEA	ETV7	16	Q9Y603
HICSPATLDPALQAM	CROCC2	391	H7BZ55
SSCHMGISKDPIFVP	FGGY	296	Q96C11
CPMIHIPGFTFPVVE	DHX36	381	Q9H2U1
FPPHTTEMTSECQAP	CMYA5	856	Q8N3K9
CSAPMQEKVTLHLFP	CRAMP1	386	Q96RY5
EFMLVAHGPVCKISP	FOSL2	181	P15408
AEMCLHTAGPTFPEE	BCL6	486	P41182
FCVLSPLPTVLGHMH	GHRHR	11	Q02643
PSVMLHGSPVQSSCA	MBD5	276	Q9P267
EMVTPLVTNPGHVCI	NSMAF	201	Q92636
DCIPLFHGTLALAPM	EMC8	56	O43402
FDPEMPLQACLVHTS	DNAH9	2441	Q9NYC9
DPQSPLCVHIMLSGT	CREG1	141	O75629
KEMGPHVPNVTSLCL	CAND2	291	O75155
IPVHMAAVGCPISSL	DLEC1	1231	Q9Y238
TGVHCTCPVGFMLQP	SCUBE3	256	Q8IX30
LPFCAMGVSSVIHPK	CPOX	236	P36551
PAHGPTNIMVYISIC	NIPA1	181	Q7RTP0
LSICFNEKGPVHAMP	C4orf19	251	Q8IY42
FTPTIPHCSMATLIG	CIAO2B	86	Q9Y3D0
MFCDQEPVFSPHLVS	JADE3	686	Q92613
CPSALHGLSQAMKLP	FOCAD	1506	Q5VW36
QCLPMISHDSFPNRL	LRRN1	421	Q6UXK5
SNEIRHVFCDMPPLL	OR5T3	201	Q8NGG3
SIPGMHNPDKFEVFC	OGT	576	O15294
CVVEMEGNQTVLHPP	KIF13A	26	Q9H1H9
PVSSCQMRFDGPLHV	NR4A2	186	P43354
PFHIPVALSRCSEMV	FUT3	71	P21217
MGQVLPVFAHCKEAP	RTN2	1	O75298
KEIPNFPTLVGHTMC	UPP2	201	O95045
PIMAFAFVCHPEVLP	SLC38A3	291	Q99624
DMLCTHEETFGPLAP	ALDH5A1	431	P51649
SFVVERQPCMPTHPQ	STAT1	316	P42224
FVVETQPCMPQTPHR	STAT2	316	P52630
MEFPLAQICPQGSHE	SH2D2A	1	Q9NP31
EPCMYVAVVAHGPSI	SH3BP4	446	Q9P0V3
SMVTKFCSGLAPHFP	STRIP2	251	Q9ULQ0
MASDPIFTLAPPLHC	SLC22A17	1	Q8WUG5
PPLCLNFLGLTHMDS	LMBRD2	486	Q68DH5
MPLASLFVDQPGSCE	MAP3K21	631	Q5TCX8
VLGMPLDSCHFRTKP	PLCE1	1896	Q9P212
TVPIMAFAFVCHPEV	SLC38A5	261	Q8WUX1
INCVTFPHPDTMPEQ	GAS7	176	O60861
IVFSACRMPPSHQLD	ARHGAP1	86	Q07960
ILTNCVFMAQHDPPP	SCN5A	141	Q14524
LLEGCPEAATTMHFP	SHROOM4	106	Q9ULL8
FLDIHPVTGIPMNCS	SCARB1	371	Q8WTV0
VSIIAGRPMHCQVPG	TENM2	1446	Q9NT68
CIIPNETKTPGAMEH	MYH4	676	Q9Y623
AACEGNMQPLHVSVP	WDR17	911	Q8IZU2
VTTLPVPGMHFQCAP	SGMS2	176	Q8NHU3
FQMPKDVIISPHNCG	SVEP1	501	Q4LDE5
HTSCGSLPMIPNAFI	SVEP1	3061	Q4LDE5
HRSCPPPVFMASVTL	RHBDL1	191	O75783
MEHAVAPCVLYPGTE	KBTBD11	1	O94819
TDSMAPHPCRDFVVL	STARD8	911	Q92502
AMLVCSTPQFPHGVI	SGPL1	281	O95470
VFSLHCPSVPMAGVT	SLCO4A1	471	Q96BD0
TPRPGSHTIEFFEMC	PRKAA1	536	Q13131
CSQFIPMEIISAPRH	ALDH1L1	86	O75891
LGNCTFPHLRPEMDA	CLN5	141	O75503
PEQTPVVVHVCGLEM	CIZ1	476	Q9ULV3
ILVMSFIGHDQVPAP	RIOK3	356	O14730
PLHIPGSMSEVQELC	TNNI2	51	P48788
EMVAKPPVICSHFPQ	ZNF100	101	Q8IYN0
HTGPITCLQFNPKFM	WDR82	281	Q6UXN9
MQTCPLAFPGHVSQA	SECTM1	1	Q8WVN6
PSILTAVLHMAGPLC	SLC16A5	56	O15375
AICFGPTLMHIPDGQ	SRGAP3	656	O43295
TMFCAQQIHIPPELP	ROPN1L	6	Q96C74
ALMEHLTTCFPGVPT	STOX2	96	Q9P2F5
DAICMIHVERFTPVP	SLC7A7	346	Q9UM01
HTLCLPGLSKMEPQT	SERINC4	321	A6NH21
TLSPMEPHALVQLCG	ST14	281	Q9Y5Y6
MVRPICLPDASHVFP	ST14	726	Q9Y5Y6
EVCPLPPMVSHGDFV	SUSD4	241	Q5VX71
DHNICIFSLDSPMPL	PLAA	91	Q9Y263
QHLIKESPGPSCTLM	WDFY4	471	Q6ZS81
GPMFVREACPHQLLT	TEX101	201	Q9BY14
LCMAALKHQPQEFPT	GC	121	P02774
CLIPNETKTPGVMDH	MYH13	676	Q9UKX3
TPLLAIPTCMGFGVH	VRK3	236	Q8IV63
LHIFMAEVQVSPAGP	SIGLEC1	321	Q9BZZ2
ASFHPECLSIEMPEG	NSD3	931	Q9BZ95
GHEQMVPCSVPESDF	ZNFX1	1356	Q9P2E3
QMSLGELCHPVPLSF	TRIM14	191	Q14142
NSIMFGHLSPVRIPC	nan	36	Q8N9G6
HSNCIEVFPEVMQLP	PHLPP1	1091	O60346
GQHPALAPPALCTVM	VSIG10L2	396	P0DP72
CSENPMTETFHPTII	TENT5A	246	Q96IP4
DHCFPLPAMEEGATI	TNFRSF17	141	Q02223
DCFSGVHTDPMDVLP	HIVEP1	2236	P15822
HPDLLKDFCMNPQTV	TMEM127	76	O75204
PSLFGMPLIVPCTVH	USP6	896	P35125
CPFATGAPELMALHL	ZNF219	651	Q9P2Y4
RPLSCPNHEGKTMEF	TRIM3	111	O75382
MPVASSFVLHCPDPV	USP54	1076	Q70EL1
VPKCHPLGSFEQMEA	ATP6V0D1	126	P61421
FLGTPVMEPAFIIQH	MYO9B	621	Q13459